The present study investigated the role of the
glutathione system in
seizures induced by
diphenyl diselenide (PhSe)(2) (50 mg/kg) in rat pups (post natal day, 12-14).
Reduced glutathione (GSH) (300 nmol/site; i.c.v.), administered 20 min before (PhSe)(2), abolished the appearance of
seizures, protected against the inhibition of
catalase and δ-aminolevulinic
dehydratase (δ-ALA-D) activities and increased
glutathione peroxidase (GPx) activity induced by (PhSe)(2). Administration of l-
buthionine sulfoximine (BSO, a GSH-depleting compound) (3.2 μmol/site; i.c.v.) 24h before (PhSe)(2) increased the percentage (42-100%) of rat pups which had seizure episodes, reduced the onset for the first convulsive episode. In addition, BSO increased
thiobarbituric acid reactive species (
TBARS) levels and decreased GSH content,
catalase, δ-ALA-D and Na(+), K(+)-
ATPase activities. Treatment with sub effective doses of GSH (10 nmol/site) and d-2-amino-7-phosphonoheptanoic
acid (AP-7, an antagonist of the
glutamate site at the
NMDA receptor; 5mg/kg, i.p.) abolished the appearance of
seizures induced by (PhSe)(2) in rat pups. Sub effective doses of GSH and
kynurenic acid (an antagonist of
strychnine-insensitive
glycine site at the
NMDA receptor; 40 mg/kg, i.p.) were also able in abolishing the appearance of
seizures induced by (PhSe)(2). In conclusion, administration of GSH protected against seizure episodes induced by (PhSe)(2) in rat pups by reducing oxidative stress and, at least in part, by acting as an antagonist of
glutamate and
glycine modulatory sites in the
NMDA receptor.